Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
about
Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microgliaImmunocompetent murine models for the study of glioblastoma immunotherapyCurrent review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunitySynergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursProduction of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1Annexin A2 promotes glioma cell invasion and tumor progressionEffective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells.Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interactionSequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumorsDifferential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of gliomaMonocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survivalImproved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model.Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.Brain Tumor Immunotherapy: What have We Learned so Far?Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype.Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma CellsA Zebrafish Live Imaging Model Reveals Differential Responses of Microglia Toward Glioblastoma Cells In Vivo.A systematic review and meta-analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma.Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).Integrating the glioblastoma microenvironment into engineered experimental models.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.Glioma-induced SIRT1-dependent activation of hMOF histone H4 lysine 16 acetyltransferase in microglia promotes a tumor supporting phenotype.Immunotherapies for malignant glioma.Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
P2860
Q28538650-C9DE176F-4B97-4E69-B75B-3BD9E3C77707Q33574853-AF3CBCD1-4199-4691-9AA3-D16DD5179039Q34198939-1E487205-8787-469E-89CC-6B567221D1B7Q34415743-3CF525CD-5296-46C0-8C48-504783DC29C0Q34744875-AB5BF9C5-0072-451B-ACC9-7A1010554B04Q35060701-7A1B0A4A-1DC8-42F0-99EC-51686EF1984CQ35448499-12CF4402-D732-4151-AAE9-59A987A1C1C6Q35561280-C677F6DA-4603-4964-9739-E51AB0BB33AFQ35663008-4367F226-48C5-4A0B-A84F-BBCBC5101274Q35760658-CA0EF673-3F00-4ABB-9770-B0AD79197E32Q35917464-140F06E7-511B-496C-9386-1B69B82678F8Q35962460-9B8EBBC9-7E6C-4DF5-8D58-0255805044DFQ36057502-22169BCE-5617-454C-961D-B0463D1DC963Q36283743-01DA2276-91CE-4960-B48A-162B45D9A34DQ36484434-D729BC27-12A3-4222-BEE9-476C484EDF4FQ36664277-786D8296-74D0-4390-936F-621E37DDCD06Q36747249-99294F65-5064-44B2-879C-A7F7885D5793Q38542113-4C05E363-938D-4166-A320-17B4D9006F7AQ38739992-51E9608C-D7F9-4AED-8C8E-777F9771583BQ38785852-6C504AC5-6F05-4A8B-999F-676514572C10Q38806032-8E9335BB-A531-46D8-9C2C-7820CEC42C46Q38964404-2FE19562-164F-4722-B13A-5F73694521A9Q39036703-78C7F319-00D3-41A6-BAC8-89FDB542060DQ39049644-DF922C29-4340-4120-8692-6CA378DA5520Q39147759-F0D84633-3C2C-44E7-A49E-2EE49F3BC1DDQ39196377-0BA23D3C-4A16-4A5B-93B1-DED2B5D551EBQ40041237-C0C4235F-170D-4DF1-B519-77573D04EFD0Q40082476-EBB317F6-E49E-4882-B2FC-A9724DDE253CQ41141280-D61C72E6-4230-4207-9ECC-C4BF2F53C527Q41609024-B8E41219-C0EE-4F4F-8DEC-BD86A8A54A49Q42639856-367EB247-899A-4EC4-B1D8-EC5DFA0C3176Q47879278-C64E8884-E221-4B7E-93DD-FB3CC860BB50Q47915209-F83680A4-4CF7-4931-B953-976EADDA2CCCQ48329275-AEB841B3-3996-44F0-8F76-F02610FBC0B5Q54980235-99398B40-BE15-450A-A82C-A2CD15AEF22FQ58545762-1CBE0AED-E01B-40C0-9D33-E42ABBBC3317
P2860
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental immunotherapy for ...... f research in the GL261 model.
@en
Experimental immunotherapy for ...... f research in the GL261 model.
@nl
type
label
Experimental immunotherapy for ...... f research in the GL261 model.
@en
Experimental immunotherapy for ...... f research in the GL261 model.
@nl
prefLabel
Experimental immunotherapy for ...... f research in the GL261 model.
@en
Experimental immunotherapy for ...... f research in the GL261 model.
@nl
P2860
P1476
Experimental immunotherapy for ...... f research in the GL261 model.
@en
P2093
Stefaan W Van Gool
P2860
P2888
P304
P356
10.1007/S00262-010-0946-6
P577
2010-12-01T00:00:00Z